Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) |
Date |
Article Title | Journal |
|---|---|---|---|
|
Gerd Rippin, Nicolás Ballarini, Héctor Sanz, Joan Largent, Chantal Quinten & Francesco Pignatti |
July 2022 | A Review of Causal Inference for External Comparator Arm Studies | Springer Nature Switzerland AG |
|
Daniele Modonutti MD,Sami E. Majdalany MD,Nicholas Corsi BS,Pin Li PhD,Akshay Sood MD,Deepansh Dalela MD,Marcus L. Jamil MD,Clara Hwang MD,Mani Menon MD,Craig G. Rogers MD,Quoc-Dien Trinh MD,Giacomo Novara MD,Firas Abdollah MD |
July 2022 | A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis | The Prostate |
|
Jue Hou, Rachel Zhao, Tianrun Cai |
June 2022 | Temporal Trends in Clinical Evidence of 5-Year Survival Within Electronic Health Records Among Patients With Early-Stage Colon Cancer Managed With Laparoscopy-Assisted Colectomy vs Open Colectomy | JAMA Network Open |
|
Garrett S Bullock,Patrick Ward,Scott Peters, Amelia Joanna Hanford Arundale , Andrew Murray,Franco M Impellizzeri, Stefan Kluzek |
June 2022 | Call for open science in sports medicine | British Journal of Sports Medicine |
|
Sophia Z. Shalhout, Kevin S. Emerick, Howard E. Kaufman, David M. Miller |
June 2022 | A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma | Journal of Clinical Oncology |
|
Chongyang Duan,Ao Yuan &Ming T. Tan |
May 2022 | Robust estimates of regional treatment effects in multiregional randomized clinical trials with ordinal responses | Journal of Biopharmaceutical Statistics |
|
Jiang Y, Cai D, Shi S |
April 2022 | Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies | Dovepress |
|
Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho |
April 2022 | Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials | Sage Journals |
|
Hiroyuki Saeki, Takuji Komeda, Risa Tanaka, Yuki Yamatani & Hironori Sakai |
March 2022 | Estimation of a Suitable Number of Patients for Selective Safety Data Collection (ICH E19 Draft Guideline): When is the Safety Profile of a Drug Well Characterized? | Therapeutic Innovation & Regulatory Science |
|
T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry |
March 2022 | Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel | Clinical Oncology |
|
Steffen Ventz, Sean Khozin, Bill Louv, Jacob Sands, Patrick Y. Wen, Leah Comment, Brian M. Alexander, Lorenzo Trippa |
March 2022 | The Design and Evaluation of Hybrid Controlled Trials that Leverage External Data and Randomization | Research Square |
|
Siddharth Ramchandran, Gleb Tikhonov, Otto Lönnroth, Pekka Tiikkainen, Harri Lähdesmäki |
March 2022 | Learning Conditional Variational Autoencoders with Missing Covariates | arXiv |
|
Ahmad Y. Abuhelwa, Sarah Badaoui, Hoi-Yee Yuen, Ross A. McKinnon, Warit Ruanglertboon, Kiran Shankaran, Anniepreet Tuteja, Michael J. Sorich & Ashley M. Hopkins |
February 2022 | A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma | Cancer Chemotherapy and Pharmacology |
|
Saki Nishiyama, Mamoru Narukawa |
February 2022 | Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials | The Oncologist |
